PMID: 9167653May 1, 1997Paper

Drug-induced nephrotoxicity

The Medical Clinics of North America
D Choudhury, Z Ahmed

Abstract

Drug-induced renal dysfunction is not an uncommon event, which can cause significant morbidity and can be easily overlooked. Many medications can lead to renal dysfunction through various mechanisms. The most common medications or classes of medications along with their clinical presentations are discussed in this article. As can be noted, many drugs can cause nephropathy in more than one way. Because it is difficult to discuss nephrotoxicities of every reported medication, Tables 1, 2, and 3 are provided; although these tables are by no means comprehensive, they may serve as further reference. This article is intended to provide a broad overview of the spectrum of presentation associated with drug-induced nephrotoxicity to guide the clinician to familiarity with this entity.

References

Jun 1, 1979·Annals of Internal Medicine·R L Schilsky, T Anderson
Nov 1, 1978·The American Journal of Medicine·J E GalpinR J Glassock
Jul 1, 1992·Journal of the American Society of Nephrology : JASN·T TakenakaM Epstein
Jul 1, 1990·The Medical Clinics of North America·M S Paller
Dec 11, 1986·The New England Journal of Medicine·C R NolanS P Kelleher
Jun 1, 1985·The American Journal of Medicine·J Carmichael, S W Shankel
Oct 2, 1986·The New England Journal of Medicine·M PackerN Medina
Aug 1, 1987·Kidney International·G Remuzzi
Dec 1, 1986·Kidney International·B D Myers
Jul 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·L GirouxL Giroux
Dec 1, 1971·The American Journal of Medicine·M H GaultR C Muehrcke
May 1, 1972·The Journal of Clinical Investigation·I SingerJ B Puschett
Aug 1, 1971·The American Journal of Medicine·H O Cutting
Jan 3, 1970·British Medical Journal·O M EdwardsR T Taylor
Nov 1, 1970·Arthritis and Rheumatism·D S SilverbergR A Ulan
Jul 1, 1984·Annals of Internal Medicine·A M JacksonR G Narins
Feb 17, 1983·The New England Journal of Medicine·J J CurtisH P Dustan
Mar 1, 1984·The New England Journal of Medicine·D M Clive, J S Stoff
Jan 1, 1984·American Journal of Nephrology·P A Abraham, W F Keane
Feb 1, 1980·AJR. American Journal of Roentgenology·R A OlderW Thompson
Apr 1, 1980·Clinical Pharmacology and Therapeutics·B R JonesM M Reidenberg
Feb 1, 1980·Kidney International
Nov 1, 1981·Annals of Internal Medicine·J D Blachley, J B Hill
Jul 1, 1982·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·H D HumesT C Knauss
Jan 1, 1981·Nephron·G B AppelJ Weissman
Nov 1, 1980·Kidney International·G J Kaloyanides, E Pastoriza-Munoz
Mar 11, 1993·The New England Journal of Medicine·M J ChoiT R Kleyman
Jul 1, 1996·AJR. American Journal of Roentgenology·R Weissleder

❮ Previous
Next ❯

Citations

Feb 11, 2000·The Annals of Pharmacotherapy·L D Wazny, D F Brophy
Jan 14, 2005·The International Journal of Artificial Organs·H M Oudemans-van Straaten
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Jared A Jaffe, Paul L Kimmel
Aug 6, 2010·The Journal of Toxicological Sciences·Anurag PayasiVivek Kumar Dwivedi
Feb 24, 2012·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Jack W SharkeyB Kevin Park
Sep 25, 2017·British Journal of Clinical Pharmacology·Rachel S HaywardJonathan D C Ross
Apr 29, 2004·The Annals of Pharmacotherapy·Brian A Hemstreet
Sep 19, 2020·Journal of Experimental Pharmacology·Muluken Altaye AyzaAbera Hadgu Berhe
Jan 5, 2002·Journal of Chemotherapy·V Fanos, L Cataldi
Nov 6, 2008·Expert Opinion on Drug Safety·Stephanie S Taber, Deborah A Pasko
Jul 30, 2020·International Journal of Toxicology·Miriam E Mossoba, Robert L Sprando
Dec 1, 2007·Electrolyte & Blood Pressure : E & BP·Yang Wook Kim
Aug 28, 2002·The Annals of Pharmacotherapy·Maria C Pruchnicki, Joseph F Dasta
Apr 30, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kevin NashSusan Hou
Feb 6, 2004·Best Practice & Research. Clinical Anaesthesiology·Robert J Anderson, Daniel W Barry
Feb 11, 2003·The Medical Clinics of North America·Anthony J Joseph, Steven L Cohn
Sep 22, 2001·The Medical Clinics of North America·B F Edwards
Dec 20, 2007·Oral and Maxillofacial Surgery Clinics of North America·Lee R Carrasco, Joli C Chou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Dermatology
F A Krumlovsky
Disease-a-month : DM
H D Humes, J M Weinberg
Journal of Clinical Pharmacology
R PiephoA Laddu
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis
A Leblanc, A Vernet
© 2021 Meta ULC. All rights reserved